CIK 0001346830
- Non-accelerated filer
- Smaller reporting company
Tvardi Therapeutics, Inc.
Sign in to watch- Ticker
- TVRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 713-489-8654
- Business address
- 3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
- Former names
- Cara Therapeutics, Inc., Cara Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | −6,256 | $9.71 | $61K | 93,527 |
| 2023-03-03 | Goncalves Joana Chief Medical Officer | Sale | −6,221 | $9.71 | $60K | 58,885 |
| 2023-03-01 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2023-03-01 | Maynard Ryan D Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2023-03-01 | Goncalves Joana Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2023-03-01 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2023-03-01 | Posner Christopher President and CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-02-16 | Goncalves Joana Chief Medical Officer | Sale | −2,265 | $10.20 | $23K | 65,106 |
| 2023-02-08 | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | Sale | −7,770 | $0.53 | $4K | 94,293 |
| 2023-02-08 | Maynard Ryan D CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −5,488 | $0.53 | $3K | 8,012 |
| 2023-02-08 | Goncalves Joana CHIEF MEDICAL OFFICER | Sale | −7,770 | $0.53 | $4K | 59,411 |
| 2023-02-02 | Posner Christopher President and CEO | Sale | −4,191 | $11.80 | $49K | 182,370 |
| 2023-01-17 | Goncalves Joana Chief Medical Officer | Sale | −2,265 | $10.81 | $24K | 67,371 |
| 2023-01-02 | von Moltke Lisa Director | Grant or award · Stock Option (Right to Buy) | +45,841 | 45,841 | ||
| 2022-12-29 | Goncalves Joana Chief Medical Officer | Sale | −2,265 | $10.18 | $23K | 69,636 |
| 2022-12-21 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Sale | −3,506 | $11.27 | $40K | 166,275 |
| 2022-12-21 | Goncalves Joana Chief Medical Officer | Sale | −2,992 | $11.27 | $34K | 71,901 |
| 2022-12-21 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | −2,561 | $11.27 | $29K | 99,783 |
| 2022-11-16 | Posner Christopher President and CEO | Sale | −14,470 | $11.13 | $161K | 186,561 |
| 2022-09-14 | VOGELBAUM MARTIN Director | Sale | −10,800 | $10.28 | $111K | 44,988 |
Page 6 of 7 · 123 trades